{"id":"W2910793117","doi":"10.1136/annrheumdis-2018-eular.6474","title":"AB0692 Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkers","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; University of California, San Francisco; National Institutes of Health; Canadian Institutes of Health Research; InflaRx; European League Against Rheumatism; Medpace; Alexion Pharmaceuticals; Genentech; National Center for Advancing Translational Sciences; Vasculitis Foundation; Bristol-Myers Squibb; AstraZeneca; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Allergy and Infectious Diseases; Medical Research Council; Celgene; Sanofi","keywords":"Medicine; Granulomatosis with polyangiitis; Microscopic polyangiitis; Rituximab; Azathioprine; Internal medicine; Gastroenterology; B-cell activating factor; Immunology; Vasculitis; Antibody; B cell","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007842522,0.0007236652,0.002842361,0.0004827846,0.0002856418,0.0006856857,0.0004627696,0.0006239845,0.001883943],"category_scores_gemma":[0.001030701,0.0003212341,0.001056214,0.0004323264,0.00029048,0.0006706336,0.0003075439,0.001816326,0.0004456381],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000365848,"about_ca_system_score_gemma":0.0004597593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000518552,"about_ca_topic_score_gemma":0.001019461,"domain_scores_codex":[0.9995266,0.000205915,0.00004356575,0.0000600743,0.00007170868,0.00009212425],"domain_scores_gemma":[0.9995084,0.0001371106,0.0001177594,0.00003065002,0.00003050864,0.0001756758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.5177596,0.01023692,0.0153571,0.001444506,0.003133907,0.0008155944,0.000127878,0.001211856,0.05585759,0.0002097638,0.00269762,0.3911476],"study_design_scores_gemma":[0.2033988,0.4464152,0.2689016,0.0006196843,0.01164977,0.003912647,0.0002641168,0.008521788,0.04167677,0.0008771372,0.01353495,0.0002276162],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9649706,0.03143977,0.0004540509,0.0007896978,0.0003024912,0.0001840236,0.0003159773,0.0001648508,0.00137839],"genre_scores_gemma":[0.9939864,0.003671578,0.0008813551,0.0002983895,0.0001953179,0.0001010682,0.0002883766,0.00001314137,0.0005643379],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002842361,"threshold_uncertainty_score":0.006302476,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00945603689777595,"score_gpt":0.2712616510775186,"score_spread":0.2618056141797426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}